The market is segmented based on Segmentation, By Diseases (Pulmonary Arterial Hypertension and Others), Drugs (Epoprostenol, Treprostinil, Iloprost, and Others), Drug Type (Generic and Branded), Dosage (Oral, Parenteral, Inhalations, and Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) – Industry Trends and Forecast to 2032
.
The Global Prostacyclin Market size was valued at USD 990.61 USD Million in 2024.
The Global Prostacyclin Market is projected to grow at a CAGR of 9.58% during the forecast period of 2025 to 2032.
The major players operating in the market include Toray IndustriesInc. , Bayer AG , GSK plc , Teva Pharmaceuticals Industries Ltd. , United Therapeutics Corporation , Sandoz Group AG , Dr. Reddys Laboratories Ltd. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.